Literature DB >> 18418301

Association of Mobiluncus curtisii with recurrence of bacterial vaginosis.

Michelle C Meltzer1, Renee A Desmond, Jane R Schwebke.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18418301      PMCID： PMC3793327          DOI： 10.1097/OLQ.0b013e318167b105

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN： 0148-5717            Impact factor:   2.830


× No keyword cloud information.
  13 in total

Review 1.  The vaginal microbial ecosystem and resistance to HIV.

Authors:  S L Hillier
Journal:  AIDS Res Hum Retroviruses       Date:  1998-04       Impact factor: 2.205

2.  A randomized trial of the duration of therapy with metronidazole plus or minus azithromycin for treatment of symptomatic bacterial vaginosis.

Authors:  J R Schwebke; R A Desmond
Journal:  Clin Infect Dis       Date:  2006-12-13       Impact factor: 9.079

3.  Comparison of gram stain, DNA probe, and culture for the identification of species of Mobiluncus in female genital specimens.

Authors:  M C Roberts; S L Hillier; F D Schoenknecht; K K Holmes
Journal:  J Infect Dis       Date:  1985-07       Impact factor: 5.226

4.  Adult vaginitis.

Authors:  F J Fleury
Journal:  Clin Obstet Gynecol       Date:  1981-06       Impact factor: 2.190

5.  Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation.

Authors:  R P Nugent; M A Krohn; S L Hillier
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

6.  Independent associations of bacterial vaginosis and Chlamydia trachomatis infection with adverse pregnancy outcome.

Authors:  M G Gravett; H P Nelson; T DeRouen; C Critchlow; D A Eschenbach; K K Holmes
Journal:  JAMA       Date:  1986-10-10       Impact factor: 56.272

7.  Susceptibility of Mobiluncus species to 23 antimicrobial agents and 15 other compounds.

Authors:  C A Spiegel
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

8.  Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations.

Authors:  R Amsel; P A Totten; C A Spiegel; K C Chen; D Eschenbach; K K Holmes
Journal:  Am J Med       Date:  1983-01       Impact factor: 4.965

9.  Classification of the genus Mobiluncus based on comparative partial 16S rRNA gene analysis.

Authors:  A Tiveljung; U Forsum; H J Monstein
Journal:  Int J Syst Bacteriol       Date:  1996-01

10.  Association of Atopobium vaginae, a recently described metronidazole resistant anaerobe, with bacterial vaginosis.

Authors:  Michael J Ferris; Alicia Masztal; Kenneth E Aldridge; J Dennis Fortenberry; Paul L Fidel; David H Martin
Journal:  BMC Infect Dis       Date:  2004-02-13       Impact factor: 3.090
View more
  15 in total

1.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

2.  The anti-HIV microbicide candidate RC-101 inhibits pathogenic vaginal bacteria without harming endogenous flora or mucosa.

Authors:  Colleen R Eade; Amy L Cole; Camila Diaz; Lisa C Rohan; Michael A Parniak; Preston Marx; Patrick M Tarwater; Phalguni Gupta; Alexander M Cole
Journal:  Am J Reprod Immunol       Date:  2012-11-20       Impact factor: 3.886

Review 3.  The Human Microbiome during Bacterial Vaginosis.

Authors:  Andrew B Onderdonk; Mary L Delaney; Raina N Fichorova
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

4.  Molecular analysis of the relationship between specific vaginal bacteria and bacterial vaginosis metronidazole therapy failure.

Authors:  B Wang; B B Xiao; C G Shang; K Wang; R S Na; X X Nu; Q Liao
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-10       Impact factor: 3.267

5.  Gemini Cationic Amphiphiles Control Biofilm Formation by Bacterial Vaginosis Pathogens.

Authors:  Ammar Algburi; Yingyue Zhang; Richard Weeks; Nicole Comito; Saskia Zehm; Juanita Pinto; Kathryn E Uhrich; Michael L Chikindas
Journal:  Antimicrob Agents Chemother       Date:  2017-11-22       Impact factor: 5.191

6.  Identification and characterization of bacterial vaginosis-associated pathogens using a comprehensive cervical-vaginal epithelial coculture assay.

Authors:  Colleen R Eade; Camila Diaz; Matthew P Wood; Kathryn Anastos; Bruce K Patterson; Phalguni Gupta; Amy L Cole; Alexander M Cole
Journal:  PLoS One       Date:  2012-11-15       Impact factor: 3.240

7.  Behavioural and medical predictors of bacterial vaginosis recurrence among female sex workers: longitudinal analysis from a randomized controlled trial.

Authors:  Fernand A Guédou; Lut Van Damme; Jennifer Deese; Tania Crucitti; Marissa Becker; Florence Mirembe; Suniti Solomon; Michel Alary
Journal:  BMC Infect Dis       Date:  2013-05-08       Impact factor: 3.090

8.  Tinidazole in the treatment of bacterial vaginosis.

Authors:  Nicola R Armstrong; Janet D Wilson
Journal:  Int J Womens Health       Date:  2010-08-09

9.  Efficacy of oral metronidazole with vaginal clindamycin or vaginal probiotic for bacterial vaginosis: randomised placebo-controlled double-blind trial.

Authors:  Catriona S Bradshaw; Marie Pirotta; Deborah De Guingand; Jane S Hocking; Anna N Morton; Suzanne M Garland; Glenda Fehler; Andrea Morrow; Sandra Walker; Lenka A Vodstrcil; Christopher K Fairley
Journal:  PLoS One       Date:  2012-04-03       Impact factor: 3.240

10.  Cationic amphiphiles against Gardnerella vaginalis resistant strains and bacterial vaginosis-associated pathogens.

Authors:  Richard M Weeks; Alysha Moretti; Shuang Song; Kathryn E Uhrich; Andrey V Karlyshev; Michael L Chikindas
Journal:  Pathog Dis       Date:  2019-11-01       Impact factor: 3.951
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.